HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

454.732

-15.126-3.22%

Number of Gainers:2

Number of Losers:46

Number of Flat:3

PE:- -

High:467.950

Open:467.950

Low:449.431

Close:469.859

Volume:144.43M

Turnover:4.43B

Market Cap:2.92T

Float Cap:2.00T

Loading ...

GenScript Bio Jumps Over 9% in Morning Trading, Cumulative Gain Nears 270% Since Early July

Hong Kong Stock Movement: GENSCRIPT BIO (01548) Surges Over 8% Again, Total Market Cap Breaks HK$100 Billion, Recently Partners with Lilly TuneLab

Hong Kong Stock Movers: mRNA Concept Stocks Lead Gains, CanSinoBIO (06185) Surges Over 17% as Moderna's mRNA Neoantigen Therapy Set to Debut at ESMO Congress

Jinxin Fertility Proposes to Launch ABS Program

Jinxin Fertility Plans Asset-Backed Special Scheme, Expects to Issue Asset-Backed Securities

Jinxin Fertility Group - Co and Project Manager Apply to SSE for Abs Program

THOMSON REUTERS

Jinxin Fertility Group - Aggregate Issuance Size of Abs to be Issued is Expected to be Rmb1,930 Mln

THOMSON REUTERS

Jinxin Fertility Group - Sanya Jinshu Will Conditionally Agree to Transfer Entire Equity Interests in Hengyu to Abs Program

THOMSON REUTERS

BlackRock Increases Stake in WuXi AppTec (02359) by About 1.167 Million Shares at Roughly HK$179.83 Each

FMR LLC Raises Stake in GENSCRIPT BIO (01548) by 6.846 Million Shares at About HK$40.25 Each

EDDING GENOR (06998) Spends HK$1.6999 Million to Repurchase 1 Million Shares on September 29

Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus

ZYLOXTB Spends HK$1.1383 Million to Repurchase 53,000 Shares on September 29

Meituan Stock Sheds 2.0% in Hong Kong

AH Premium Statistics for September 29

Innovent Says Trispecific Antibody Ibi3003 Posts 84.6% ORR at Phase 1 RP2D in Relapsed/refractory Multiple Myeloma

2026 Ims Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody Ibi3003 (Gprc5d/Bcma/Cd3) in Patients with Relapsed or Refractory Multiple Myeloma

THOMSON REUTERS

Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology

EU Withdrawal of Aumseqa Exposes Hansoh Pharma's Compliance Gaps and Global Ambitions

Beyond the Blind Spot: Three Core Signals That Reveal Blue Moon Group's Advanced Logic

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BK1583/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":454.73242,"timestamp":1790922543998,"preClose":469.8589,"halted":0,"volume":144428626,"delay":0,"changeRate":-0.032194,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-15.126465,"latestTime":"10-02 14:29:04","open":467.95047,"high":467.95047,"low":449.43094,"amount":4430652151,"amplitude":0.039415,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790928600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"pbRate":2.127366,"peRate":44.937051,"turnoverRate":0.00139,"increases":2,"decrements":46,"flats":1,"marketCap":2916739365040,"floatMarketCap":1998930552944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":467.95047,"amplitude":0.039415,"preClose":469.8589,"low":449.43094,"pbRate":"2.127366","latestPrice":454.73242,"volume":144428626,"delay":0,"open":467.95047,"prevYearClose":503.90085,"prevWeekClose":459.069,"prevMonthClose":469.859,"prevQuarterClose":469.859,"fiveDayClose":459.726,"twentyDayClose":475.543,"sixtyDayClose":432.558,"secType":"PLATE","market":"HK","turnoverRate":0.00139,"peRate":44.937051,"marketCap":2916739365040,"floatMarketCap":1998930552944,"timestamp":1790922543998,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":2,"down":46,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1147005762","title":"GenScript Bio Jumps Over 9% in Morning Trading, Cumulative Gain Nears 270% Since Early July","url":"https://stock-news.laohu8.com/highlight/detail?id=1147005762","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147005762?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:21","pubTimestamp":1790734883,"startTime":"0","endTime":"0","summary":"Hot picksData centerMarket centerCapital flowsSimulated trading clientGenScript Bio (01548) surged more than 9% in morning trading, with cumulative gains approaching 270% since early July. As of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK1583","01548","HK0000306701.USD","HK0000320264.USD","HK0000306685.HKD","BK1141","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173764682","title":"Hong Kong Stock Movement: GENSCRIPT BIO (01548) Surges Over 8% Again, Total Market Cap Breaks HK$100 Billion, Recently Partners with Lilly TuneLab","url":"https://stock-news.laohu8.com/highlight/detail?id=1173764682","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173764682?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:06","pubTimestamp":1790733978,"startTime":"0","endTime":"0","summary":"According to a report, GENSCRIPT BIO (01548) surged over 8% again, with cumulative gains of nearly 270% since early July. As of press time, it rose 8.16% to HK$44.78, with a trading volume of HK$438...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","HK0000306685.HKD","BK1576","HK0000320264.USD","KCAI","BK4585","HK0000306701.USD","01548","VXUS","BK1141","BK1583","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154987922","title":"Hong Kong Stock Movers: mRNA Concept Stocks Lead Gains, CanSinoBIO (06185) Surges Over 17% as Moderna's mRNA Neoantigen Therapy Set to Debut at ESMO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=1154987922","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154987922?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:02","pubTimestamp":1790733739,"startTime":"0","endTime":"0","summary":"mRNA concept stocks are leading the gains, with CanSinoBIO (06185) rising 16.78% to HK$36.32 as of press time.Everest Medicines (01952) is up 4.29% at HK$29.18, 3D Medicines (01244) has gained 1.94%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01244","BK1191","07666","VXUS","BK1161","BK4588","BK1574","KCAI","01952","06185","BK4585","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671245196","title":"Jinxin Fertility Proposes to Launch ABS Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2671245196","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671245196?lang=en_us&edition=fundamental","pubTime":"2026-09-29 23:56","pubTimestamp":1790697403,"startTime":"0","endTime":"0","summary":"BRIEF-Jinxin Fertility Proposes To Launch ABS ProgramSept 29 (Reuters)-Jinxin Fertility Group Limited1951.HK:PROPOSES TO LAUNCH ABS PROGRAMAGGREGATE ISSUANCE SIZE OF ABS TO BE ISSUED IS EXPECTED TO BE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1XJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1597","01951","BK1219","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174932311","title":"Jinxin Fertility Plans Asset-Backed Special Scheme, Expects to Issue Asset-Backed Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1174932311","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174932311?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:58","pubTimestamp":1790693906,"startTime":"0","endTime":"0","summary":"Jinxin Fertility (01951) has announced that it intends to launch an asset-backed special scheme and expects to issue asset-backed securities to be listed and transferred on the Shanghai Stock...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SECR","TSEC","FSEC","BK1597","PINC","01951","BKAG","DBL","TRBF","JSCP","DIAL","MBS","PSDM","OOSP","ASEC","UYLD","BK1219","EVG","CGMS","DEED","PSQO","GISC","SCIO","OGSP","PKO","BK1583","JPLD","DMBS","JSI","DABS","SECU","NSCI","TOTL","VABS","WDE","DSCO","DMX","BK4196","HYIN","JABS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671248039","title":"Jinxin Fertility Group - Co and Project Manager Apply to SSE for Abs Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2671248039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671248039?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:46","pubTimestamp":1790693160,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1XJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1597","BK1219","01951","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671248033","title":"Jinxin Fertility Group - Aggregate Issuance Size of Abs to be Issued is Expected to be Rmb1,930 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2671248033","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671248033?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:46","pubTimestamp":1790693160,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1XJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1597","BK1583","01951","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671248014","title":"Jinxin Fertility Group - Sanya Jinshu Will Conditionally Agree to Transfer Entire Equity Interests in Hengyu to Abs Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2671248014","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671248014?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:46","pubTimestamp":1790693160,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1XJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1597","BK1583","01951","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170578260","title":"BlackRock Increases Stake in WuXi AppTec (02359) by About 1.167 Million Shares at Roughly HK$179.83 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1170578260","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170578260?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:34","pubTimestamp":1790681665,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, BlackRock increased its holdings of WuXi AppTec (02359) by 1,167,015 shares on September 24, at a price of HK$179.8314 per share, for a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572944931.SGD","603259","LU0611395673.USD","LU0700851271.USD","LU0348767384.USD","IE00BPRC5H50.USD","LU2495084118.USD","BK1576","LU1251922891.USD","LU1303224171.USD","02359","LU1719994722.HKD","LU0052750758.USD","LU0456842615.SGD","LU1934453819.USD","LU1997245177.USD","LU1997245094.SGD","LU0708995583.HKD","BK1583","IE00B5MMRT66.SGD","LU2488822045.USD","LU2045819591.USD","LU2328871848.SGD","LU1979443071.USD","LU1997244956.HKD","LU0320764599.SGD","LU0469268626.HKD","EWH","LU2242644610.SGD","IE00B543WZ88.USD","LU1969619763.USD","LU0327786744.USD","BK1141","LU0348766576.USD","LU1046422090.SGD","LU2125910500.SGD","BK0216","LU1808992512.USD","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198440420","title":"FMR LLC Raises Stake in GENSCRIPT BIO (01548) by 6.846 Million Shares at About HK$40.25 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1198440420","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198440420?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:34","pubTimestamp":1790681653,"startTime":"0","endTime":"0","summary":"According to the latest disclosures from the Hong Kong Stock Exchange, FMR LLC increased its holdings in GENSCRIPT BIO (01548) by 6.846 million shares on September 24.The shares were purchased at...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","HK0000306685.HKD","BK1576","01548","HK0000306701.USD","EWH","HK0000320223.HKD","BK1141","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121622936","title":"EDDING GENOR (06998) Spends HK$1.6999 Million to Repurchase 1 Million Shares on September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1121622936","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121622936?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:50","pubTimestamp":1790679009,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) announced that on September 29, 2026, the company spent HK$1.6999 million to repurchase 1 million shares, at a repurchase price of HK$1.695 to HK$1.7 per share.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06998","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101970069","title":"Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus","url":"https://stock-news.laohu8.com/highlight/detail?id=1101970069","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101970069?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:29","pubTimestamp":1790674165,"startTime":"0","endTime":"0","summary":"Shenzhen Lifotronic Technology Co.,Ltd. (688389.SH) has announced that its controlling subsidiary, Chongqing Lifotronic Biotechnology Co., Ltd., recently received the Medical Device Registration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688389","BK1574","BK1583","BK0251","GDOC","HART","LGHT","LNGR","MEDX","PTH","RSPH","AGNG","IEIH","159883","09996","BK1100","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111891998","title":"ZYLOXTB Spends HK$1.1383 Million to Repurchase 53,000 Shares on September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1111891998","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111891998?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:58","pubTimestamp":1790672320,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has announced that on September 29, 2026, the company spent HK$1.1383 million to repurchase 53,000 shares, with a repurchase price ranging from HK$21.36 to HK$21.54 per share.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1587","BK1100","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671292136","title":"Meituan Stock Sheds 2.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2671292136","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671292136?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:32","pubTimestamp":1790670720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Meituan shed 2.0% to 70.45 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.5% to 24523.57.Meituan closed 35% short of its 52-week high of HK$108.00, which the company achieved Jan. 6.Trading volume totaled 33.6 million shares, compared to the 50-day average of 38.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348805143.USD","IE00B543WZ88.USD","LU0828238088.HKD","METmain","LU0072913022.USD","LU1102505762.USD","LU0588545904.SGD","LU0823040885.USD","LU0463099449.HKD","LU0594300419.USD","LU0214875030.USD","LU1808992512.USD","LU1102505929.USD","LU2097828714.EUR","LU2097828631.EUR","MPNGY","LU1831875114.USD","LU0315178854.USD","LU0561508036.HKD","LU0173614495.USD","LU0359201885.HKD","LU0417516902.SGD","LU1064130708.USD","LU0873338254.USD","LU0823041008.USD","IE0008368742.USD","LU0054237671.USD","LU2039709279.SGD","SG9999014674.SGD","LU0871576103.HKD","IE0008369823.USD","LU0611395673.USD","LU0132412106.USD","LU0143863784.USD","LU1188198961.HKD","BK1575","SG9999000327.SGD","LU0320764599.SGD","LU0823039010.USD","SG9999002828.SGD","LU1328277881.USD","BK1583","BK1591","LU0327786744.USD","LU2097828805.USD","LU1880383366.USD","LU1323998911.USD","LU0231483743.USD","LU0456846285.SGD","LU0588546209.SGD","LU0244354667.USD","LU0540923850.HKD","IE0032431581.USD","LU1770036033.HKD","LU0307460666.USD","LU0918141705.HKD","LU0029875118.USD","LU2242644610.SGD","IE00B5MMRT66.SGD","LU0348825331.USD","LU0048580855.USD","LU0588545730.USD","LU0823038988.USD","LU1770034418.SGD","LU0140636845.USD","LU1720050803.USD","LU1008478684.HKD","LU0543330483.HKD","LU0650527681.SGD","LU0345775950.USD","LU0106252389.USD","LU2097828557.USD","LU0449509016.USD","LU1226287529.USD","IE00B0JY6N72.USD","LU0117841782.USD","LU0228659784.USD","LU0499858602.USD","LU0918141887.USD","LU1064131003.USD","LU2226246903.HKD","LU1868837722.USD","LU0577902371.SGD","LU0593848301.USD","IE0034224299.USD","LU0269904917.USD","LU0128522157.USD","LU0149721374.USD","LU0143863198.USD","BK1618","LU0011963245.USD","LU0047713382.USD","LU0164880469.USD","LU0577902611.USD","LU0572944931.SGD","LU2257852520.SGD","LU0345776255.USD","LU0868486357.SGD","BK1142","LU0708995583.HKD","LU1105468828.SGD","LU0823426308.USD","LU1303224171.USD","LU0196878994.USD","LU0823426480.USD","LU2087589342.USD","BK1521","LU0359202008.SGD","SG9999002562.SGD","LU0737861699.HKD","LU0348735423.USD","LU0210526637.USD","LU2045819591.USD","LU1152091754.HKD","LU1242518857.USD","LU0084288322.USD","LU0261950983.USD","LU0856984785.SGD","LU1880383440.USD","LU0359201612.USD","LU0502904849.HKD","LU0633140560.USD","LU0797268264.HKD","LU1251922891.USD","LU0048597586.USD","LU0072462343.USD","LU0431992006.USD","SG9999001689.USD","LU0043850808.USD","BK1589","IE00B29SXG58.USD","LU0449515922.USD","LU2476274720.SGD","LU0880133367.SGD","LU0700851271.USD","LU0577902454.USD","LU0979878070.USD","IE00B3M56506.USD","LU2148510915.USD","LU0251144936.SGD","LU0164865239.USD","SG9999002463.SGD","BK1615","LU1048588211.SGD","LU0326950275.SGD","LU0051755006.USD","LU0348827113.USD","LU1734074674.USD","LU2778985437.USD","LU0501845795.SGD","LU0165289439.USD","LU0067412154.USD","LU1960683339.HKD","LU2488822045.USD","LU0878005551.USD","BK1233","LU1993786604.SGD","LU1242518931.SGD","LU0828237510.HKD","LU0054450605.USD","LU1868838027.USD","LU0320764755.SGD","LU0348814723.USD","LU2152927971.USD","SG9999001903.USD","LU0052750758.USD","LU1328615791.USD","LU0348816934.USD","LU1794554557.SGD","LU0821914370.USD","LU0541502299.USD","LU1048596156.SGD","LU0370786039.SGD","LU1152091168.USD","KWEB","LU1224709979.USD","LU0164872284.USD","LU0577902538.SGD","LU2399975544.HKD","LU0819123356.HKD","LU0588545490.SGD","03690","LU0499858438.USD","LU0326948709.USD","LU0683595622.HKD","LU1023057109.AUD","LU0181495838.USD","LU0509642566.USD","LU1813983027.USD","LU0314109678.HKD","LU0049853897.USD","LU0634319403.HKD","LU0211977185.USD","LU1675838814.USD","LU0541501648.USD","IE00BF5LJ272.USD","LU0605514214.HKD","LU0828237940.HKD","LU1719994722.HKD","LU0039217434.USD","LU2097828474.EUR","SG9999000459.SGD","LU0577902298.EUR","LU0531971595.HKD","IE00B031HY20.USD","LU0594300179.USD","IE00BPRC5H50.USD","LU0455707207.USD","LU0672654166.SGD","LU1688375341.USD","LU1868837565.USD","LU0865486749.SGD","LU1961090484.USD","LU1282648689.USD","BK1610","LU0348788117.USD","LU0417516738.SGD","LU0287142896.SGD","LU2476274308.USD","LU0633140727.USD","LU1807302812.USD","BK1604","LU1481107354.HKD","HMTD.SI","LU2125910500.SGD","LU0819121731.USD","LU0589944569.HKD","LU0456827905.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140639624","title":"AH Premium Statistics for September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1140639624","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140639624?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:21","pubTimestamp":1790670095,"startTime":"0","endTime":"0","summary":"As of the market close on September 29, NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) ranked as the top three stocks by AH premium rate, with premium rates of 1155.81%,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1610","BK1116","01108","LU0593848301.USD","LU0918141705.HKD","LU0072913022.USD","IE00BZ08YS42.EUR","02218","02846","IE00BMCWC346.EUR","IE0008368742.USD","LU0067412154.USD","00991","IE00BGHQDM52.EUR","LU0797268264.HKD","BK1546","LU0149721374.USD","BK1507","BK1190","03328","01057","LU0052750758.USD","IE00B543WZ88.USD","LU2226246903.HKD","LU2097828805.USD","LU0516422440.USD","LU2097828714.EUR","HK0000352382.USD","BK1521","IE00BZ08YR35.GBP","LU0823426308.USD","BK1515","LU0431992006.USD","LU0672654166.SGD","BK1125","BK1141","BK1539","00568","BK1530","01033","LU0348805143.USD","LU1224709979.USD","LU1211504680.USD","IE0034224299.USD","LU0320764599.SGD","LU0048580855.USD","LU2097828557.USD","HK0001040168.HKD","LU0327786744.USD","LU0823426480.USD","BK1144","LU2097828474.EUR","LU0329678337.USD","LU0417516902.SGD","LU1282649141.HKD","00811","LU1960683339.HKD","LU1366334578.USD","02338","IE0008369823.USD","LU0417516738.SGD","BK1522","LU0106959298.USD","LU0648948544.HKD","LU2476274308.USD","BK1122","LU2294711473.HKD","06951","BK1237","LU0348814723.USD","LU0348788117.USD","BK1544","03200","LU0531970944.HKD","LU0821914370.USD","LU0307460666.USD","BK1191","BK1554","LU0128522157.USD","LU0329678170.USD","LU1675838814.USD","LU1115378108.SGD","BK1183","LU0828237510.HKD","LU0228659784.USD","IE00B031HY20.USD","BK1562","SG9999011746.SGD","02359","BK1583","LU0049853897.USD","BK1202","LU0348825331.USD","BK1193","03968","HK0000306701.USD","BK1170","LU0456827905.SGD","83188","LU1255011170.USD","LU1282649067.USD","LU0082770016.SGD","LU0266512127.USD","01812","SG9999001226.SGD","06185","LU1282648689.USD","LU0516423174.USD","82843","LU0561508036.HKD","LU0516422366.SGD","LU1481107354.HKD","02899","LU1366334651.USD","LU1282649810.SGD","82846","HK0000306685.HKD","LU0039217434.USD","LU1504937902.USD","LU0117841782.USD","LU0455707207.USD","LU0463099449.HKD","159982","LU3063872942.SGD","06127","IE00B3M56506.USD","HK0001040143.USD","LU1303224171.USD","LU1988902786.USD","LU0886674414.USD","LU2242644610.SGD","03986","LU0061477393.USD","LU1048596156.SGD","BK1223","SG9999006597.SGD","LU0708995583.HKD","LU0181495838.USD","LU1831875114.USD","LU0043850808.USD","BK1249","LU0214875030.USD","LU1807302812.USD","LU2097828631.EUR","LU0348816934.USD","BK1171","LU0918141887.USD","LU0328353924.USD","02238","LU2045819591.USD","LU0320764755.SGD","LU1244550577.SGD","SG9999004220.SGD","LU0634319403.HKD","BK1119","00042","03750","LU0228367735.SGD","SG9999002463.SGD","02691","LU2177674079.SGD","LU0140636845.USD","07233","LU0266512473.USD","LU0589944569.HKD","02865","BK1594","LU0384037296.USD","LU1152091754.HKD","LU0229945570.USD","BK1147","LU0345780521.USD","LU0348735423.USD","LU1769817179.HKD","IE00BF5LJ272.USD","LU0531971595.HKD","BK1533","LU0359201885.HKD","LU0348766576.USD","LU0449509016.USD","LU1064131342.USD","LU0051755006.USD","03308","LU0173614495.USD","LU2039709279.SGD","LU0359201612.USD","03143","LU0149534421.HKD","LU0588546209.SGD","02827","09976","03188","00553","LU1244550221.USD","LU1688375341.USD","IE00B031J352.USD","LU0572944931.SGD","LU2778985437.USD","LU0359202008.SGD","LU0348767384.USD","LU1328277881.USD","LU1023057109.AUD","LU0326950275.SGD","LU0502904849.HKD","LU0029875118.USD","LU0287142896.SGD","BK1149","LU1251922891.USD","BK1198","EWH","HK0000352291.HKD","82823","LU1961090484.USD","LU0890818403.SGD","LU1655091616.SGD","IE0032431581.USD","BK1231","LU1880383440.USD","LU0607220059.USD","LU0543330566.HKD","BK1574","02823","02822","LU1188198961.HKD","LU1242518857.USD","LU0868486357.SGD","LU1226287529.USD","LU0211977185.USD","06067","BK1163","LU0231483743.USD","LU0862451753.SGD","02843","LU1046422090.SGD","LU0164939612.USD","LU0314109678.HKD","LU0082770016.USD","BK1560","BK1181","LU0516423091.SGD","SG9999002828.SGD","LU0164880469.USD","LU2476274720.SGD","02701","LU0540923850.HKD","LU0979878070.USD","IE00BZ08YT58.USD","LU1770034418.SGD","LU0488056044.USD","06821","BK1505","LU0164865239.USD","LU2264538146.SGD","BK1105","BK1130","LU1206782309.USD","LU0737861699.HKD","BK1514","LU1008478684.HKD","LU0106252389.USD","IE00B5MMRT66.SGD","03996","LU0345780281.USD","LU0791590937.USD","LU0163747925.USD","LU0501845795.SGD","BK1551","LU1880383366.USD","LU0269904917.USD","LU0871576103.HKD","82822","LU0348827113.USD","01349","HK0000320223.HKD","IE00BYV24P56.USD","LU0456854461.SGD","LU1242518931.SGD","BK1110","IE00BVYPNQ40.USD","03228","LU1993786604.SGD","LU0828238088.HKD","LU0509642566.USD","LU2008162690.USD","83130","BK1576","03130","LU1794554557.SGD","LU2399975544.HKD","LU0737861772.HKD","LU1152091168.USD","LU0254981946.USD","SG9999014674.SGD","03678","LU2125910500.SGD","LU1719994722.HKD","BK1592","LU0543330483.HKD","LU1105468828.SGD","IE0031814852.USD","LU0469268626.HKD","LU0828237940.HKD","LU0315179316.USD","IE00BVYPNP33.GBP","LU0516422952.EUR","LU1813983027.USD","LU0370786039.SGD","BK1161","LU0244354667.USD","399300","LU1808992512.USD","00187","LU1769817096.USD","02475","SG9999001093.SGD","LU0165289439.USD","LU0880133367.SGD","LU0456846285.SGD","LU0640798160.USD","BK1564","LU0791591158.USD","LU0096374516.USD","LU1244550494.USD","LU1720050803.USD","HK0000320264.USD","LU0210526637.USD","LU0620787316.HKD","BK1148","IE00B29SXG58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671914282","title":"Innovent Says Trispecific Antibody Ibi3003 Posts 84.6% ORR at Phase 1 RP2D in Relapsed/refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671914282","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671914282?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:46","pubTimestamp":1790667978,"startTime":"0","endTime":"0","summary":"Innovent says trispecific antibody IBI3003 posts 84.6% ORR at Phase 1 RP2D in relapsed/refractory multiple myelomaInnovent disclosed updated Phase 1 results for IBI3003 in relapsed or refractory multi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLTnt3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0244354667.USD","LU0607220059.USD","LU1188198961.HKD","BK1589","BK1583","LU2097828805.USD","LU1831875114.USD","BK1161","LU2097828631.EUR","LU0326950275.SGD","LU0455707207.USD","BK1147","LU2097828714.EUR","LU0463099449.HKD","LU2097828474.EUR","LU2488822045.USD","LU2242644610.SGD","LU0502904849.HKD","LU1969619763.USD","LU2328871848.SGD","KURE","01801","01911","HK0000165453.HKD","LU0149534421.HKD","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671291456","title":"2026 Ims Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody Ibi3003 (Gprc5d/Bcma/Cd3) in Patients with Relapsed or Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671291456","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671291456?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:45","pubTimestamp":1790667949,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA3L9QVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0149534421.HKD","LU0326950275.SGD","HK0000165453.HKD","BK1583","BK1161","LU1969619763.USD","01801","LU2097828557.USD","LU2097828805.USD","KURE","LU2488822045.USD","LU0455707207.USD","LU2242644610.SGD","LU0244354667.USD","LU2097828631.EUR","LU2328871848.SGD","LU0607220059.USD","LU1831875114.USD","LU0463099449.HKD","LU2097828474.EUR","LU0502904849.HKD","LU1188198961.HKD","BK1589","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110569578","title":"Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=1110569578","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110569578?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:50","pubTimestamp":1790661039,"startTime":"0","endTime":"0","summary":"Keymed Bio-B (02162) rose more than 8% in afternoon trading, climbing 8.95% as of press time to HKD 79.70, with a turnover of HKD 237 million.Earlier this month, Keymed Bio-B (02162) announced that...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1587","BK1161","02162","IBBQ","BK1583","MEDX","BK1574","159992","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164655618","title":"EU Withdrawal of Aumseqa Exposes Hansoh Pharma's Compliance Gaps and Global Ambitions","url":"https://stock-news.laohu8.com/highlight/detail?id=1164655618","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164655618?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:00","pubTimestamp":1790647247,"startTime":"0","endTime":"0","summary":"On September 25, 2026, the European Commission formally revoked the marketing authorization for Hansoh Pharma's almonertinib mesylate tablets, sold overseas under the brand name Aumseqa®, merely...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","FSXEmain","BK1589","FESXmain","03692","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105459029","title":"Beyond the Blind Spot: Three Core Signals That Reveal Blue Moon Group's Advanced Logic","url":"https://stock-news.laohu8.com/highlight/detail?id=1105459029","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105459029?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:58","pubTimestamp":1790647107,"startTime":"0","endTime":"0","summary":"Since the start of this year, the market has paid extremely close attention to the performance and dividend arrangements of Blue Moon Group (06993). Amid recent swings in market sentiment, the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1102","06993"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":3,"totalSize":237,"code":"91000000","status":"200"}]}}